Thomas Watkins

Insider Reports History

Location
Naples, FL
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Watkins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. Director Common Stock 63,064 $368,294 $5.84 02 Jun 2022 Direct
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 By Family Limited Partnership
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 By Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co Director Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co Director Stock Option (Right to Buy) 0 06 Oct 2023 Direct
Vanda Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 02 Jun 2022 Direct

Insider Reports Filed by Thomas Watkins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123052376-watkins-thomas-2023-10-06 Horizon Therapeutics Public Ltd Co 06 Oct 2023 8 -$20,550,600 4 Director 06 Oct 2023, 18:24
/report/000120919123051234-watkins-thomas-2023-09-29 Horizon Therapeutics Public Ltd Co 29 Sep 2023 6 +$1,106,550 4 Director 02 Oct 2023, 19:32
/report/000120919123043698-watkins-thomas-2023-07-27 Horizon Therapeutics Public Ltd Co 27 Jul 2023 1 $0 4 Director 28 Jul 2023, 16:41
/report/000120919123026757-watkins-thomas-2023-04-28 Horizon Therapeutics Public Ltd Co 28 Apr 2023 2 $0 4 Director 02 May 2023, 19:32
VNDA Vanda Pharmaceuticals Inc. 02 Jun 2022 3 -$1,529 4 Director 03 Jun 2022, 16:31
/report/000120919122026471-watkins-thomas-2022-04-28 Horizon Therapeutics Public Ltd Co 28 Apr 2022 3 $0 4 Director 02 May 2022, 18:15
VNDA Vanda Pharmaceuticals Inc. 10 Jun 2021 2 $0 4 Director 14 Jun 2021, 16:37